Appetite Suppressant Overrides Opioid-Driven Hunger — But Not Through Serotonin | Research

The takeaway

Dexfenfluramine's appetite-suppressing effect dominated over opioid peptide feeding stimulation in rats, and the interaction did not involve brain serotonin changes.

Suppression dominated stimulation
Dexfenfluramine's anorectic effect overrode opioid agonist feeding stimulation without altering brain serotonin turnover

What the researchers found

Dexfenfluramine's anorectic effect dominated over opioid agonist feeding stimulation. The interaction was not mediated by brain serotonin turnover changes.

Why it matters

Understanding how appetite-stimulating (opioid) and appetite-suppressing (serotonergic) systems interact is key to developing better weight loss treatments.

How the study worked

Rats received central injections of opioid agonists (beta-endorphin, dynorphin, DSLET) or naltrexone, alone or combined with d-FF. Food intake and brain serotonin turnover were measured.

What this study cannot tell us

Animal study in rats with central drug administration. Doses and routes do not reflect clinical use. d-FF was later withdrawn from human use due to safety concerns.

How to read the evidence

Preliminary animal study. The drug was later withdrawn from human use due to safety concerns.

When this study was published

Published in 1991. Dexfenfluramine was withdrawn in 1997 due to heart valve problems, but the principles of appetite system interactions remain relevant.

The bigger picture

Understanding how appetite-stimulating and appetite-suppressing systems interact is key to obesity treatment. This study showed serotonergic appetite suppression can override opioid-driven hunger.

Questions still open

What mechanism underlies the dexfenfluramine-opioid interaction if not serotonin?
Could combination therapies targeting both systems improve weight loss?

Common questions

Why was dexfenfluramine withdrawn?

It was removed from the market in 1997 because it caused heart valve damage in some patients. However, the appetite research findings remain scientifically valid.

Does this mean serotonin drugs can overcome opioid hunger?

In this model, yes. Serotonergic appetite suppression dominated over opioid-driven feeding. Modern weight loss drugs like lorcaserin (also later withdrawn) worked on similar principles.

Read the original research

Effects of dexfenfluramine and opioid peptides, alone or in combination, on food intake and brain serotonin turnover in rats.

Pharmacology, biochemistry, and behavior, 38(4), 775-80

View on PubMed ↗

Citation

Robert, J J; Orosco, M; Rouch, C; Cohen, Y; Jacquot, C. (1991). Effects of dexfenfluramine and opioid peptides, alone or in combination, on food intake and brain serotonin turnover in rats.. Pharmacology, biochemistry, and behavior, 38(4), 775-80.